Bayer AG
XETRA:BAYN
Bayer AG
Total Current Liabilities
Bayer AG
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Total Current Liabilities
€29.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Total Current Liabilities
$20.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Total Current Liabilities
€8.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
8%
|
|
MPH Health Care AG
XETRA:93M1
|
Total Current Liabilities
€4.2m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
79%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Total Current Liabilities
€394.5m
|
CAGR 3-Years
44%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Total Current Liabilities
€22.7m
|
CAGR 3-Years
42%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Total Current Liabilities?
Total Current Liabilities
29.5B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Total Current Liabilities amounts to 29.5B EUR.
What is Bayer AG's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
8%
Over the last year, the Total Current Liabilities growth was -16%. The average annual Total Current Liabilities growth rates for Bayer AG have been -7% over the past three years , 5% over the past five years , and 8% over the past ten years .